DEBORAH A. HOGERMAN - Concepedia

Concepedia

Author

DEBORAH A. HOGERMAN

University at Buffalo, State University of New York

Also Known As

D HOGERMAN, D. A. Hogerman, D. HOGERMAN, D. Hogerman, DEBORAH A. HOGERMAN, Deborah A Hogerman, Deborah A. Hogerman, Deborah Hogerman

15

Publications

1.1K

Citations

10

H-Index

7

Concepts

All Affiliations

University at Buffalo, State University of New York Women & Children's Hospital of Buffalo Baylor College of Medicine Praxis

DA

About

DEBORAH A. HOGERMAN is an author at University at Buffalo, State University of New York specializing in vaccine development, respiratory virus immunity, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	38
2	Immunology	1	1	38
3	Respiratory Virus Immunity	1	1	38
4	Vaccine Development	1	1	38
5	Respiratory Diseases	1	1	38

DEBORAH A. HOGERMAN

×

10

Publications

1.1K

Citations

10

H-Index

	Year	Citations
Safety and Immunogenicity of Heptavalent Pneumococcal Vaccine Conjugated to CRM197 in United States Infants Margaret B. Rennels, Kathryn M. Edwards, Harry Keyserling, PEDIATRICS	1998	395
Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis Pedro A. Piedra, SUSAN GRACE, Alan M. Jewell, The Pediatric Infectious Disease Journal	1996	138
Immunogenicity and Safety of Respiratory Syncytial Virus Subunit Vaccine in Seropositive Children 18-36 Months Old Debra Tristram, Charles Welliver, Claudia K. Mohar, The Journal of Infectious Diseases	1993	126
A randomized comparison of three bivalent Streptococcus pneumoniae glycoprotein conjugate vaccines in young children M. C. Steinhoff, Kathryn M. Edwards, Harry Keyserling, The Pediatric Infectious Disease Journal	1994	103
Infant Immunization with Pneumococcal CRM $_{197}$ Vaccines: Effect of Saccharide Size on Immunogenicity and Interactions with Simultaneously Administered Vaccines Robert S. Daum, DEBORAH A. HOGERMAN, Margaret B. Rennels, The Journal of Infectious Diseases	1997	94
Safety and immunogenicity of a subunit respiratory syncytial virus vacine in children 24 to 48 months old Peter R. Paradiso, Stephen W. Hildreth, DEBORAH A. HOGERMAN, The Pediatric Infectious Disease Journal	1994	93
Safety and Immunogenicity of a Combined Diphtheria, Tetanus, Pertussis and <i>Haemophilus influenzae</i> Type b Vaccine in Young Infants Peter R. Paradiso, DEBORAH A. HOGERMAN, Dace V. Madore, PEDIATRICS	1993	72
Sequential annual administration of purified fusion protein vaccine against respiratory syncytial virus in children with cystic fibrosis Pedro A. Piedra, SUSAN GRACE, Alan M. Jewell, The Pediatric Infectious Disease Journal	1998	50
Second-year surveillance of recipients of a respiratory syncytial virus (RSV) F protein subunit vaccine, PFP-1: Evaluation of antibody persistence and possible disease enhancement Debra Tristram, R WELLIVER, DEBORAH A. HOGERMAN, Vaccine VaccinationRespiratory Virus ImmunityVaccine DevelopmentAntibody PersistenceRespiratory Diseases	1994	38
Respiratory Syncytial Virus-Specific Cell-Mediated Immune Responses after Vaccination with a Purified Fusion Protein Subunit Vaccine Charles Welliver, Debra Tristram, Katharine Batt, The Journal of Infectious Diseases	1994	26

Page 1